Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Antimalarial Drug Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 95

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Antimalarial Drug Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 95 | Format : PDF

In 2017, the global Antimalarial Drug market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.

This report focuses on the global Antimalarial Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antimalarial Drug development in United States, Europe and China.

The key players covered in this study
    Pfizer
    GlaxoSmithKline
    Ranbaxy Laboratories
    Ipca Laboratories Ltd
    Zydus Cadila
    Merck KGaA
    Novartis AG
    Alvizia Health Care
    Bayer
    Roche

Market segment by Type, the product can be split into
    Plasmodium Falciparum
    Plasmodium Vivax
    Plasmodium Malariae
    Plasmodium Ovale

Market segment by Application, split into
    Hospital Pharmacy
    Retail Pharmacy
    E-Commerce
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Antimalarial Drug status, future forecast, growth opportunity, key market and key players.
    To present the Antimalarial Drug development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antimalarial Drug are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
<pre>Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Antimalarial Drug Market Size Growth Rate by Type (2013-2025) 1.4.2 Plasmodium Falciparum 1.4.3 Plasmodium Vivax 1.4.4 Plasmodium Malariae 1.4.5 Plasmodium Ovale 1.5 Market by Application 1.5.1 Global Antimalarial Drug Market Share by Application (2013-2025) 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 E-Commerce 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Antimalarial Drug Market Size 2.2 Antimalarial Drug Growth Trends by Regions 2.2.1 Antimalarial Drug Market Size by Regions (2013-2025) 2.2.2 Antimalarial Drug Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Antimalarial Drug Market Size by Manufacturers 3.1.1 Global Antimalarial Drug Revenue by Manufacturers (2013-2018) 3.1.2 Global Antimalarial Drug Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Antimalarial Drug Market Concentration Ratio (CR5 and HHI) 3.2 Antimalarial Drug Key Players Head office and Area Served 3.3 Key Players Antimalarial Drug Product/Solution/Service 3.4 Date of Enter into Antimalarial Drug Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Antimalarial Drug Market Size by Type (2013-2018) 4.2 Global Antimalarial Drug Market Size by Application (2013-2018) 5 United States 5.1 United States Antimalarial Drug Market Size (2013-2018) 5.2 Antimalarial Drug Key Players in United States 5.3 United States Antimalarial Drug Market Size by Type 5.4 United States Antimalarial Drug Market Size by Application 6 Europe 6.1 Europe Antimalarial Drug Market Size (2013-2018) 6.2 Antimalarial Drug Key Players in Europe 6.3 Europe Antimalarial Drug Market Size by Type 6.4 Europe Antimalarial Drug Market Size by Application 7 China 7.1 China Antimalarial Drug Market Size (2013-2018) 7.2 Antimalarial Drug Key Players in China 7.3 China Antimalarial Drug Market Size by Type 7.4 China Antimalarial Drug Market Size by Application 8 Japan 8.1 Japan Antimalarial Drug Market Size (2013-2018) 8.2 Antimalarial Drug Key Players in Japan 8.3 Japan Antimalarial Drug Market Size by Type 8.4 Japan Antimalarial Drug Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Antimalarial Drug Market Size (2013-2018) 9.2 Antimalarial Drug Key Players in Southeast Asia 9.3 Southeast Asia Antimalarial Drug Market Size by Type 9.4 Southeast Asia Antimalarial Drug Market Size by Application 10 India 10.1 India Antimalarial Drug Market Size (2013-2018) 10.2 Antimalarial Drug Key Players in India 10.3 India Antimalarial Drug Market Size by Type 10.4 India Antimalarial Drug Market Size by Application 11 Central & South America 11.1 Central & South America Antimalarial Drug Market Size (2013-2018) 11.2 Antimalarial Drug Key Players in Central & South America 11.3 Central & South America Antimalarial Drug Market Size by Type 11.4 Central & South America Antimalarial Drug Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Antimalarial Drug Introduction 12.1.4 Pfizer Revenue in Antimalarial Drug Business (2013-2018) 12.1.5 Pfizer Recent Development 12.2 GlaxoSmithKline 12.2.1 GlaxoSmithKline Company Details 12.2.2 Company Description and Business Overview 12.2.3 Antimalarial Drug Introduction 12.2.4 GlaxoSmithKline Revenue in Antimalarial Drug Business (2013-2018) 12.2.5 GlaxoSmithKline Recent Development 12.3 Ranbaxy Laboratories 12.3.1 Ranbaxy Laboratories Company Details 12.3.2 Company Description and Business Overview 12.3.3 Antimalarial Drug Introduction 12.3.4 Ranbaxy Laboratories Revenue in Antimalarial Drug Business (2013-2018) 12.3.5 Ranbaxy Laboratories Recent Development 12.4 Ipca Laboratories Ltd 12.4.1 Ipca Laboratories Ltd Company Details 12.4.2 Company Description and Business Overview 12.4.3 Antimalarial Drug Introduction 12.4.4 Ipca Laboratories Ltd Revenue in Antimalarial Drug Business (2013-2018) 12.4.5 Ipca Laboratories Ltd Recent Development 12.5 Zydus Cadila 12.5.1 Zydus Cadila Company Details 12.5.2 Company Description and Business Overview 12.5.3 Antimalarial Drug Introduction 12.5.4 Zydus Cadila Revenue in Antimalarial Drug Business (2013-2018) 12.5.5 Zydus Cadila Recent Development 12.6 Merck KGaA 12.6.1 Merck KGaA Company Details 12.6.2 Company Description and Business Overview 12.6.3 Antimalarial Drug Introduction 12.6.4 Merck KGaA Revenue in Antimalarial Drug Business (2013-2018) 12.6.5 Merck KGaA Recent Development 12.7 Novartis AG 12.7.1 Novartis AG Company Details 12.7.2 Company Description and Business Overview 12.7.3 Antimalarial Drug Introduction 12.7.4 Novartis AG Revenue in Antimalarial Drug Business (2013-2018) 12.7.5 Novartis AG Recent Development 12.8 Alvizia Health Care 12.8.1 Alvizia Health Care Company Details 12.8.2 Company Description and Business Overview 12.8.3 Antimalarial Drug Introduction 12.8.4 Alvizia Health Care Revenue in Antimalarial Drug Business (2013-2018) 12.8.5 Alvizia Health Care Recent Development 12.9 Bayer 12.9.1 Bayer Company Details 12.9.2 Company Description and Business Overview 12.9.3 Antimalarial Drug Introduction 12.9.4 Bayer Revenue in Antimalarial Drug Business (2013-2018) 12.9.5 Bayer Recent Development 12.10 Roche 12.10.1 Roche Company Details 12.10.2 Company Description and Business Overview 12.10.3 Antimalarial Drug Introduction 12.10.4 Roche Revenue in Antimalarial Drug Business (2013-2018) 12.10.5 Roche Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details</pre>


 Latest Research Reports